Novaquest Capital Management
16
59M
16
1.23
4
8
- Stages of investment
- Areas of investment
Summary
Novaquest Capital Management appeared to be the VC, which was created in 2010. The company was established in North America in United States. The main department of described VC is located in the Raleigh.
The higher amount of exits for fund were in 2014. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 50 - 100 millions dollars. The typical startup value when the investment from Novaquest Capital Management is more than 1 billion dollars. This Novaquest Capital Management works on 11 percentage points more the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 40 percentage points more often commits exit comparing to other companies.
The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Roivant Sciences, PreCision Dermatology, Clinical Ink. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Medical, Health Care.
We also calculated 10 valuable employees in our database.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Novaquest Capital Management, startups are often financed by FCA Venture Partners, Viking Global Investors, SoftBank Investment Advisers. The meaningful sponsors for the fund in investment in the same round are Viking Global Investors, TT Capital Partners, SoftBank Investment Advisers. In the next rounds fund is usually obtained by Silicon Valley Bank, RTI International, CIBC.
Investments analytics
Analytics
- Total investments
- 16
- Lead investments
- 4
- Exits
- 8
- Rounds per year
- 1.23
- Investments by industry
- Biotechnology (15)
- Health Care (10)
- Pharmaceutical (6)
- Medical (3)
- Clinical Trials (2) Show 14 more
- Investments by region
-
- United States (10)
- Switzerland (2)
- United Kingdom (1)
- Sweden (1)
- Australia (1) Show 1 more
- Peak activity year
- 2018
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 485M
- Group Appearance index
- 0.56
- Avg. company exit year
- 5
- Avg. multiplicator
- 2.09
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Applied LifeSciences & Systems | 25 May 2022 | Biotechnology, Aquaculture, Life Science, Innovation Management | Late Stage Venture | 35M | United States, North Carolina |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.